Interpace Biosciences Inc (OTCPK:IDXGD)
$ 7.62 +0.37 (+5.08%) Market Cap: 42.20 Mil Enterprise Value: 40.49 Mil PE Ratio: 1.71 PB Ratio: 9.07 GF Score: 41/100